Polaryx Therapeutics Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Polaryx Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $7.50. The average 1-year stock price forecast is 258.85% higher than the current stock price, while the lowest is $6.00 (+187.08%) and the highest is $10 (+378.47%).

Price Target: $7.50 (+258.85%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$6.00	$7.50	$7.00	$10
Change	+187.08%	+258.85%	+234.93%	+378.47%

Analyst Ratings

The average analyst rating for Polaryx Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	Jul '26	Aug '26
Strong Buy	0	0	0	2	3
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tiago Fauth Raymond James	Raymond James	Buy Initiates $6	Buy	Initiates	$6	+187.08%	Aug 13, 2026
Dev Prasad Lucid Capital	Lucid Capital	Buy Initiates $7	Buy	Initiates	$7	+234.93%	Jul 27, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Maintains $10	Buy	Maintains	$10	+378.47%	Apr 22, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-
Operating Income	-3.78M	-4.35M	-7.82M	-8.44M
Net Income	-3.78M	-30.36M	-8.99M	-9.16M
Free Cash Flow	-	992.00K	505.87K	-8.10M
No. Analysts	-	-	-	4

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

Chart

EPS Growth	2027	2028
High	-
Avg	-
Low	-